Clinical Trials in Denver

Showing 11321-11340 of 18,161 trials

Safety of PDT-Photofrin® Prior to Lung Surgery

NCT03344861

This research study is being conducted to assess the safety of PDT in subjects with peripherally located malignant tumors in lung parenchyma prior to surgical resection. It will involve up to 10 sites in USA. Participation will last 4 months.

Lung CancerLung Cancer Metastatic

Concordia Laboratories Inc.10 participantsStarted Aug 2017

Los Angeles, California, United States • Denver, Colorado, United States • Tampa, Florida, United States +5 more locations

COMPLETEDPhase 1< 1 mile

This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)

NCT03165227

The main objective of this trial is the safety and tolerability of 3 multiple rising oral doses of BI 685509 over 28 days in male and female patients with Diabetic Nephropathy (DN) as adjunctive to Angiotensin Converting Enzyme inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB). Another objective is the change in Urine Albumin Creatinine Ratio (UACR), an important diagnostic marker of nephropathy.

Diabetic Nephropathies

Boehringer Ingelheim75 participantsStarted Oct 2017

Huntsville, Alabama, United States • La Mesa, California, United States • Los Gatos, California, United States +32 more locations

Safety of PDT-Photofrin® Prior to Lung Surgery

This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)

Find Trials by Condition in Denver

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia

Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

Study to Evaluate DNL201 in Subjects With Parkinson's Disease

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

A Study of Gene Polymorphisms Associated With Specific Presentations of Sexual Addiction

A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

Radiesse® Safety Study For the Treatment of Hands

Answer ALS: Individualized Initiative for ALS Discovery

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

An Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Urothelial Carcinoma

ReNu™ Injection to Treat Hip Osteoarthritis Study

Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord Injury

Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade